Latest News about Biotech and Pharmaceuticals
Recent news which mentions Biotech and Pharmaceuticals
From CNBC.com News
From CNBC.com News
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
October 01, 2024
From CNBC.com News
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
September 26, 2024
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
September 25, 2024
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
September 24, 2024
From CNBC.com News
From CNBC.com News
FTC sues drug middlemen for allegedly inflating insulin prices
September 20, 2024
From CNBC.com News
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
September 18, 2024
From CNBC.com News
From CNBC.com News
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
September 16, 2024
From CNBC.com News
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
September 14, 2024
From CNBC.com News
Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future
September 12, 2024
From CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
September 12, 2024
From CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
September 10, 2024
From CNBC.com News
AstraZeneca shares fall 5% on disappointing lung cancer drug trial results
September 10, 2024
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.